Normal growth and development is the result of a complex interplay of endogenous and exogenous factors. In no other organ is it more important to understand the factors involved and to get the â€˜¿ mixture' right than in the brain, which plays such a vital role in controlling the relationship of the organism to its environment. The brain in Down's syndrome weighs less than normal (Crome & Stern, 1972) , and is rounded in Shape, largely due to the smallness of the frontal lobes. Other abnormalities include narrowness of gyri, the superior temporal gyrus being most frequently in volved, while the brain stem and cerebellum are also small. Sylvester (1983) measured the hippocampi in 20 patients with Down's syndrome, and found they were significantly smaller thanthoseof13controls, matched for age. Congenitial deformities of the brain conform with the high incidence of congenital malformations in otherorgansâ€"35.6 percentin2,421children (Fabia& Drolette, 1970) .
Congenital and developmental abnormalities are being investigated in other maladies. Lejeune (1981) demonstratedthatfolates couldreducethe count of
Fragile-X chromosomes; he claims successful treat ment in patients with Fragile-X syndrome and postu lates that folic acid can be used to treat children with Down's syndrome, (Lejeune, 1983) . Smithells et al (1981) have claimed that penconceptional multi vitamin supplementation can protect women who had previously given birth to infants with neural tube defects from having further deformed babies. Law rence et al (1981) narrowed the gap in a study which 115 pointedtofolates asbeingprotective towomen atrisk in similar circumstances. Erway (1971)was able to preventataxia intheoffspring of pallid mice mutants by feeding manganese supplements to the mothers.
There have been claims that multi-vitamins and nutritional supplementshelp the Down's syndrome child. Turkel(1963) recognised different clinical types of Down's syndrome,and devisedvarious patterns of vitaminand drugtreatments accordingly. Harrell etal (1981) , usingmegavitamindoseswithtraceelements, claimedimprovement intheintelligence and physical appearance of mentally handicapped children, includ ing three with Down's syndrome. However, so far, vitamin, mineral and other forms of treatment, includinghormones and amino acidsfor Down's syndrome, have not been sustained. One reasonfor this isthatdeficiency states have notbeen defined.
The vitamin, trace element, and pathological studies reported here took place in St. Lawrence's Hospital, Caterham, where the patients have lived most of their lives. Thus, they had a constantenvironment,and were supplied with the same diet, similarly prepared. Entwistle (1974) confirmed that the nutritional content of the diet was adequate for health.
Vitamin studies
Low serum vitamin A (Sobel et al, 1958) and impaired absorption of the vitamin (Auld et al, 1959) have both been found. Impaired dark adaptation was demonstrated by Gnffiths & Behrman (1966) and Palmer (1978) showed that children were short of vitamin A, which was associated with increased Trace element studies Barlow et a! (1981) , using atomic absorption spectroscopy, estimated the trace element contents of sub-occipital hair in 69 male and 67 female patients with Down's syndrome and compared the results with 69 control patients in the same environment, eight staff, and 86 people living in Birmingham (Table I) .
Multiple deficiencies occurred. Levels belowâ€"i SD of the means of the hospital control population revealed that three or more deficiencies were found in 13 per cent of the males and in 8 per cent of the females, two deficiencies in 41 per cent males and 34 per cent females, and one deficiency in 29 per cent males and 34 per cent females. Deficiencies were not found in 17 per cent males and 24 per cent females.
There were striking differences in manganese and copper between the sexes. Manganese levels in females with Down's syndrome were significantly lower than in women without Down's syndrome (P = 0.001), but there were no comparative differences between male Down's syndrome and other males. However, differences were significant between male and female Down's syndrome (P = 0.001). The sex differences for copper, in contrast, were significantly more reduced in males than in females with Down's syndromes (P = 0.001).
The coeruloplasm in levels of six male and five female patients with Down's syndrome who had low copper hair results ranged from 24.0 to 48.4 mg/100 ml. and were within normal limits (15 â€"¿ 60 mg/100 ml).
Studies on ten children with Down's syndrome, aged 14 to 17 years, living at home and attending a school in Surrey, revealed that they too were low in hair calcium, copper, and manganese (Table II) , and therefore matched the findings in the adult Down subjects. This pattern of deficiencies is presented throughout life. The question then arises as to whether or not these complex deficiencies can be related to chemical and pathological processes.
The nervous systemâ€"anatomical and patho logicalfeatures
As mentioned above, the brain in Down's syndrome is smaller than normal. Gray's Anatomy quotes 1294 g as the weight of a female brain and 1430 gas the weight of a male brain, at the age of 20 years. Seventeen brains from female Down's syndrome (22â€"70years) gave a mean weight of 968 g (range 706 to 1176 g) and a mean for 16 males (18â€"69)of 1114 g range 935 to 1359 g). Thus, there is a weight deficiency of about 300 gin both sexes, or a volume of 297 cm3, using 1.0103 g/cm3 as the volume of brain tissue (Gleser & Blinkov 1968 . D'Arcy Thompson (1963 used a grid system of vertical and horizontal co-ordinates over an outline of one creature (e.g. porcupine fish).
He then drew out the vertical co-ordinates with a system of concentric circles and the horizontal ones with a system of curves and superimposed an outline 
Trace elements ugig
The results of trace elements (uglg) in 4 groups, the first column is the Down's Group under study, the second column is a control group of non-Down's patients living in the same environment, the third column is from a small group of hospital staff and the fourth group is from a control non-hospital population in Birmingham. Low values for calcium, copper and manganese on the Down's syndrome group are the ones under discussion. 
Comments
The evidence from the studies quoted demonstrates that patients with Down's syndromes are different from the mentally handicapped without Down's syn drome in several nutritional respects. They are prone to suffer multi-vitamin deficiencies and shortages of some trace metals; these shortages are lifelong, since similar patterns of deficiencies have been found in Down's syndrome children. A significient reason for these deficiencies is malabsorption from the gut. Dickerson et a! (1983) have shown that absorption from the intestine, using the xylose absorption test, is reduced in Down's syndrome; the test was carried out on patients who had taken part in the vitamin and hair studies.
The central nervous system is particularly vulner able to nutritional deficiencies. Early in gestation, a wide range of abnormalities including anencephaly, exencephaly anophthalmia, and spina bifida can be produced experimentally in animals by maternal deficiencies of specific nutrients. Structural abnormalities of the synaptic processes in Down's syndrome have been described by Marin Padilla (1976) and by Takashima et a! (1981) . They reported abnormal forms as well as reduction in numbers in feotuses and young infants. Takashima eta! used aged-matched controls, as a consequence, they found an age effect. The dendritic structural patterns in Down's syndrome and non-Down's syndrome foetuses respectively were the same, but in newborn and older infants, changes in dendritic structure were apparent. Thus, neuritic pathology is pin-pointed in the newborn rather than the foetus. Terry & Wisniewski (1972) found ultrastructural evidence that senile plaques have their origins in neurites. It is deduced, therefore, that the neuritic structure in Down's syndrome is the target area in which one or more deleterious factors operate. The nature of these, whether nutritional or not, has yet to be defined, but the effects are harmful for intelligence, and likely to be pathogenic for the ageing process.
More certain pathogenic roles for nutrients have been defined experimentally. Vitamin E deficiency has led to the accumulation of lipofuscin in spinal and cortical neurones (Adams, 1965) . The vitamin appears to have an antioxidant effect in protecting lipids in tissues against peroxidation and subsequent formation of lipofuscin. Adams felt that lipofuscin in neurones in adult man was not due to vitamin deficiency, but probably the result of a normal ageing process manifested by lipid peroxidation. Einarson (1954) was able to cause posterior column damage in vitamin E deficient rats; these changes were irreversible. Rudra et a! (1975) , also working with rats, although not able to influence the number of cells containing lipofuscin, were able significantly to lower the amount present in each cell after giving vitamin E, while Harmon (1961) was able to prolong the half-survival time of certain strains of mice by as much as 26 per cent by giving them an antioxident (2â€"Mercaptoethylamine HC1). 
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FIG 2â€"Oxygen radicles (0@) are converted to peroxides
(H202)through the enzyme superoxide dismutase (SOD).
Accumulation of peroxides within cells is harmful and leads to cell ageing. Glutathiomine peroxidase is the enzyme which normally deals with peroxides reducing lipid peroxidation.
Copper is part of the SOD enzymesystem, the Oi mayalso be increased by nicotinic acid and manganese. Peroxidation is reduced by selenium and vitamin E. The equation is probably unbalanced in Down's syndrome because SOD is produced in larger quantities than normal since it is controlled by No. 21 chromosome and there is a dosage effect.
The importance of selenium and vitamin E in assisting glutathionine peroxidase to control the build-up of harmful peroxidases is evident (Figure 2 Chromosomal anomalies, as well as virus infections, radiation, steroids, and inborn errors of metabolism can affect the number of neuroblasts as might appear to be the case in the Down's foetus. Davies & Davis (1970) postulate that in the human infant brain there is only a single growth spurt which is strictly age-related, and that any growth retardation that occurs is unlikely to be compensated for by subsequent catch-up growth. The growth phase can be divided into at least three phasesâ€"neuronal, glial and myelogenousâ€"any one of which in theory can be disturbed, either singly or in combination with others. If catch-up growth cannot be compensated for, then the urgency of preventing growth deficits is obvious, and it prompted the Smithell and Lawrence teams to try to successfully prevent neural tube defects by periconceptional vita min therapy. Analogy would suggest that the Down's foetus is in similar peril.
Turkel (1963) believed that nutritional studies to help Down subjects should be directed towards life in utero, and the published evidence supports this. The work of Marin-Padilla and of Takashima et a! on Down's foetuses and newborns has parallels in the newborn with phenylketonuria. It is universally known that such infants can be rescued from brain damage and their future intelligence preserved by appropriate adjustment to their diets. However, the problem is more complex in Down's syndrome. The evidence of nutritional deficiencies in later life has not been established to be present at birth or in utero.
Nevertheless, lessons borrowed from other fields, both with experimental animals and in human clinical work, strongly indicate a fertile field to explore.
